VIRTUAL POSTER ROOM GCOS 2021
The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy.
"If a poster fails to open, click the download link in the window to access the content"
Ivabradine to prevent anthracycline-induced cardiotoxicity: an ongoing prospective randomized, open-label clinical trial
Eglė Čiburienė, Greta Ščerbickaitė, Edita Baltruškevičienė, Monika Drobnienė, Jelena Čelutkienė, Sigita Aidietienė
Leave a Reply
Angiotensin II Receptor Blocker vs. Calcium Channel Blocker in the Treatment of Bevacizumab induced Hypertension: Comparison of Serum VEGF level
Boda Zhou M.D., Zhuo Yu M.D., Ping Zhang M.D.
Leave a Reply
Ibrutinib induced rhythm disorders- does inflammation play a role?
Iva Minga MD, Charile Robin, Iliana Spitz, Jason Robin MD
Leave a Reply
Intravascular leiomyomatosis with intracardiac extension: role for medical management
Dr Ryan Panchal, Dr Alexander Lyon, Dr Maria Sol Andres
Leave a Reply
Sacubitril/valsartan significant positive effect in a patient with chemotherapy associated heart failure
J. Safonova, I. Ilgisonis, M. Kozhevnikova, D. Budanova, Yu. Naimann, E. Privalova, YU. Belenkov
Leave a Reply
An Unusual Case of Toxicity Related to 5-FU Chemotherapy
George Lolay MD, Atul R Chugh MD, Ryan Daly, Meghana Raghavendra MD, and Vijay U Rao MD PhD
Leave a Reply
Predictive value of high-sensitive troponin T ratio in breast cancer treatment
Sergey Kozhukhov, Nataliia Dovganych, Ivan Smolanka, Olga Lygyrda
Leave a Reply
Acute Coronary Syndrome Secondary to Cisplatin in a Patient with Bladder Cancer: A Case Report.
AH Hernandez-Pineda, MD; N Garcia-Hernandez, MD; JD Hernandez-Guzman, MD; SA Montoya-Guerrero, MD; JF Antezana-Castro, MD; M Carillo-Estrada, MD
Leave a Reply
DOACs: a new skyline in cancer-associated thrombosis resistant to heparin. A case of seminoma in BEP Chemotherapy solved with edoxaban
Agnese Maria Fioretti, Tiziana Leopizzi, Giovanni Luzzi, Vito Lorusso, Stefano Oliva
Leave a Reply
A CARdiac Case: CD19-targeting Chimeric Antigen Receptor (CAR)-T in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Chen D H, Low R, Clark S, Thomson K, Bishton M, Walker J M, Manisty C, Ghosh A K, O’Reilly M, Roddie C
Leave a Reply
MRI reveals progression of cardiovascular function post chemotherapy in sarcoma
El-Sayed H. Ibrahim, John Charlson
Leave a Reply
Acute Pericarditis follow by Transient Myocarditis: A case of immune checkpoint inhibitor related cardiotoxicity in a 63-year-old female
Ammar Hasnie, MD, Usman Hasnie, MD, Courtney Estes, CRNP, Aparna Hegde, MD, Carrie Lenneman, MD
Leave a Reply
A rare case of severe heart failure from pemetrexed
Marina Macedo Kuenzer Bond, José Eduardo M. Barbosa, Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto João Rigon Jr, Marcelo Corassa
Leave a Reply
Successful drug rechallenge after osimertinib-related acute cardiac failure
Marina Macedo Kuenzer Bond, José Ecio Batista Rosado Jr, José Eduardo M. Barbosa, , Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto João Rigon Jr, Helano Carioca Freitas
Leave a Reply
The use of sacubitril-valsartan in a patient with anti-her2 cardiotoxicity enabling rapid recovery and re-exposure: a case report
Marina Macedo Kuenzer Bond, José Eduardo M. Barbosa, Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto Rigon Jr, Fabiana Baroni A.Makdissi, Maria Nirvana da C. Formiga
Leave a Reply
Metformin attenuates the cardiotoxicity of ibrutinib through AMPK and PI3K-Akt pathway
Pengsha Li, Ming Yuan, Daiqi Liu, Bingxin Xie, Guangping Li MD PhD, Gary Tse MD FRCP FACC, Tong Liu MD PhD FESC
Leave a Reply
Blockade of the innate immune checkpoint CD47 decreases infarct size by modulation of oxidative stress and immune response
S. Korste, P. Stock, U. Hendgen-Cotta, T. Rassaf, M. Totzeck
Leave a Reply
Can pyridoxamine tackle anthracycline-induced cardiotoxicity?
Sibren Haesen, Aline Brillouet, Iris de Laat, Lotte Vastmans, Lize Evens, Sarah D’Haese, Esther Wolfs, Dorien Deluyker, Virginie Bito
Leave a Reply
RhoA/ROCK pathway participates in the study of related mechanisms of apatinib in the treatment of breast cancer-induced hypertension
Wenjuan Wang, Haodong zhang, Qiongying Wang, Chenchen Zhuang, Xin Fan, Caie Li, Runmin Sun, Miaomiao Qi
Leave a Reply
Use Of Strain-encoded Magnetic Resonance Imaging During Chemotherapy Is Associated With Improved Left Ventricular Function And Reduced Adverse Cardiovascular Events
Felix D. Nguyen MD, Srilakshmi Vallabhaneni MD, Kaitlin Moore BS, Olivia Passafiume MS, Mary P Watkins BS, Pamela K. Woodard MD, Gregory M. Lanza MD, Daniel J. Lenihan MD
Leave a Reply
Cancer Therapy Related Cardiac Dysfunction
Sheela Sawant, Anuprita Daddi , Amey Bedekar
Leave a Reply
Cardiovascular adverse events in patients treated with anthracyclines during induction therapy for acute myeloid leukemia (AML) a systematic review and meta-analysis
Jesse Geels, Anna van Rhenen, Folkert W. Asselbergs, Marijke Linschoten
Leave a Reply
Chemotherapy-related cardiac dysfunction in breast cancer patients treated with doxorubicin, cyclophosphamide, paclitaxel with or without trastuzumab - a systematic review and meta-analysis
Louise V. Dübel, Rhodé M. Bijlsma, Janine Kamphuis, Arco J. Teske, Janine Kamphuis, Folkert W. Asselbergs, Marijke Linschoten
Leave a Reply
Left ventricular diastolic function in patients with breast cancer treated with anthracyclines – a meta-analysis
Raluca I. Mincu, PhD; Lena Lampe; Tienush Rassaf, MD; Matthias Totzeck, MD
Leave a Reply
Predective factors of cardiotoxicy in lymphoma patients receiving antrhacilines in frontline
A.LOPEZ-GARCIA , E. MACIA, S. GOMEZ TALAVERA, M. OREJAS, B. IBAÑEZ, E. CASTILLO, D. MORILLO, MA. PEREZ, E. ASKARI, P. LLAMAS, ,R. CORDOBA
Leave a Reply
Cancer Patients with Potential Eligibility for Anthracyclines Have an Increased Risk for Heart Failure
Sun, Shuyuan Zhang, Mengyan Dai, Yanli Zhang, Yunlong Xia, Ling Yiu
Leave a Reply
A Novel Diagnostic Approach for the Detection of Cardiac Dysfunction from Breast Cancer Therapy Validation Study with Cardiovascular Magnetic Resonance
Maryam MD; Camila M. Urzua Fresno, MD; Emily Somerset MSc; Tamar Shalmon MD; Eitan Amir MD PhD; Chun-Po Steve Fan PhD; Christine Brezden-Masley MD, PhD; Babitha Thampinathan RDCS, Yobiga Thevakumaran RN; Kibar Yared MD; C. Anne Koch MD PhD; Husam Abdel-Qadir MD, PhD; Anna Woo, MD, SM; Paul Yip, PhD; Thomas H. Marwick MD, PhD, MPH; Rosanna Chan BSc; Bernd J. Wintersperger MD; Paaladinesh Thavendiranathan MD, SM
Leave a Reply
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
Lars Michel; Ulrike B. Hendgen-Cotta; Raluca I. Mincu; Iris Helfrich; Sebastian Korste; Simone M. Mrotzek; Armin Spomer; Christoph Rischpler; Ken Herrmann; Lale Umutlu; Elisabeth Livingstone; Selma Ugurel; Lisa Zimmer; Cristina Coman; Robert Ahrends; Matthias Gunzer; Dirk Schadendorf; Tienush Rassaf; Matthias Totzeck
Leave a Reply
Left ventricular global longitudinal strain reduction in patients with melanoma and extracardiac immune-related adverse events during immune checkpoint inhibitor therapy
Raluca I. Mincu; Julia Pohl; Simone Mrotzek; Lars Michel; Lena Hinrichs; Lena Lampe; Tienush Rassaf; Matthias Totzeck
Leave a Reply
Immune-associated Myocarditis in Patients Receiving Camrelizumab -A single-center retrospective study
Chuan Zhang, Zhong Zuo, Zhulu Chen, Diansha Gao, Chunhua Mo, Yuxi Zhu, Shu Qin
Leave a Reply
Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: A population-based study
Sharen Lee, Jiandong Zhou , Ishan Lakhani , Lei Yang MD PhD, Tong Liu MD PhD, Yuhui Zhang MD PhD, Yunlong Xia MD PhD FACC, Wing Tak Wong PhD, Kelvin King Hei Bao MB Bchir FRCR, Ian Chi Kei Wong PhD, Gary Tse MD FRCP, FACC, Qingpeng Zhang PhD
Leave a Reply
Development of heart failure in hematopoietic stem cell transplant patients
Fernández de Sanmamed Girón M., Bautista García J., Ramonis Quintero J., Galván Ruiz M., Aguiar Bermudez B., Peña Ortega P., Torres Ochando M., González Pinedo L., López Pérez M., Groba Marco M., Mendoza Lemes H., García Quintana A., Perera Alvarez M., Caballero Dorta E.
Leave a Reply
Are there cardiological differences between autologous and allogenic Hematopoietic stem cell transplantation?
Fernández de Sanmamed Girón M., Aguiar Bermudez B., Ramonis Quintero J., Galván Ruiz M., Bautista García J., Peña Ortega P., Torres Ochando M., González, Pinedo L., López Pérez M., Groba Marco M., Mendoza Lemes H., García Quintana A., Perera Alvarez M., Caballero Dorta E.
Leave a Reply
Left ventricular dysfunction after Hematopoetic Cell Transplantation
Priscila Nasser de Carvalho, Mauro Jorge Freitas de Souza Junior
Leave a Reply
Cardiac biomarkers among men with metastatic castration-resistant prostate cancer during abiraterone acetate treatment – a prospective, single centre study.
Michał Wilk, Anna Waśko-Grabowska, Sebastian Szmit
Leave a Reply
Identification of baseline cardiovascular co-morbidities and risk factors in prostate cancer patients receiving Androgen Deprivation Therapy: RWD from UK primary care
Dr Sivatharshini Ramalingam, Dr Patrick Davey, Dr Maria Sol Andres, Jay Were, Dr Simon Wan Yau Ming and Professor Stuart Rosen
Leave a Reply
5-Flourouracil-related Cardiomyopathy and Management Strategy
Taha Ahmed, MD, Amit Arbune, MD, MHA, FACC
Leave a Reply
Risk Predictors for Fluoropyrimidine Cardiotoxicity: A Large Retrospective Institutional Analysis
AT Abiodun, M Shawe-Taylor, S Tybally, T Bajomo, S Slater, N Diamantis, C Manisty
Leave a Reply
Myocardial tissue contractility as an indicator of cardiac function post radiation therapy
El-Sayed H. Ibrahim, Luba Frank, Carmen Bergom
Leave a Reply
Thoracic irradiation leads to endothelial damage and differential immune response in mice
Simone M. Mrotzek, Florian Wirsdörfer, Sebastian Korste, Lars Michel, Lena Gockeln, Ulrike Hendgen-Cotta, Verena Jendrossek, Tienush Rassaf, Matthias Totzeck
Leave a Reply
Cardiovascular Risk and Prevention Strategies in Chinese Patients with Breast Cancer Treated with Radiotherapy: A Retrospectively Study
Yanjun Zhou, Xin Liu, Yule Hu, Haojie Yang, Tao Liang*
Leave a Reply
Safe Delivery of Radiotherapy in Patients with Cancer and CIEDs
Cehic Daniela, Eckert Marionb, Corsini Nadiab, Sharplin Gregb, Tran Phuonga
Leave a Reply
Establishment of a cardio-oncology center: Clinical practice and decision-making
Simone M. Mrotzek, Alina Röll, Raluca-I. Mincu, Tienush Rassaf, Matthias Totzeck
Leave a Reply
CARDIOTOXICITY SURVEILLANCE: UNCOVERING A “HIDDEN” DISEASE
Saraiva, M.; Moura, AR.; Castilho, B.; Veiga, R.; Craveiro, N.; Domingues, K.; Pitta, ML.; Martins, V.
Leave a Reply
Sailing in the mist: cardiotoxicity monitoring in adolescent and young adult osteosarcoma patients
JC Heemelaar, AAM al Jaff, RE Evenhuis, ES Polomski, MAJ van de Sande, AJ Gelderblom, FM Speetjens, ML Antoni